Skip to content

Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures

Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07225101
Enrollment
160
Registered
2025-11-05
Start date
2025-11-01
Completion date
2026-12-31
Last updated
2025-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Tumor Adult, Hemorrhagic Stroke, Intracerebral, Neurovascular, Spine, Traumatic Brain Injury, Wound Closure

Keywords

Superficial surgical site infection, Suture material, Wound closure techniques, brain tumor, spine, spine trauma, neurosurgery, hemorrhagic stroke, traumatic brain injury

Brief summary

This research is studying a device already approved by the Food and Drug Administration (FDA) to treat wound closures. Researchers are studying a large group of people to continue to learn information about the safety of the STRATAFIX suture and how people's bodies react to using it over a long period of time. This research will provide additional information about using STRATAFIX sutures to close surgical wounds.

Interventions

DEVICESTRATAFIX PDS and Monocryl suture

STRATAFIX, suture employs a novel incorporation of barbed components to suture resulting in tension holding closure with long-lasting absorbable suture.

Sponsors

Johnson & Johnson
CollaboratorINDUSTRY
University of Michigan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Open label, single-arm, non-crossover prospective cohort study with non-inferiority statistical analysis.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Elective or emergent surgical approaches for cranial or spine neurosurgical approaches, requiring sutures for wound closure, requiring multilayer wound closure

Exclusion criteria

* Patients with prior surgical wound dehiscence or infection * Patients with allergy to suture material

Design outcomes

Primary

MeasureTime frameDescription
Wound complications Bates-Jensen Wound Assessment Tool (BWAT) score1 monthThe BWAT evaluates 13 categories including size, depth, edges, undermining, necrotic tissue type and amount, exudate type and amount, skin color, peripheral tissue, granulation tissue and epithelialization with a total score of 65. Minimal severity scores are 10-20 out of the total of 65 with good interrater reliability and validation in a variety of clinical environments. Wounds with scores \<10 will be considered healed.

Secondary

MeasureTime frameDescription
The Wound-Quality of Life (QOL) questionnaire score1, 3 and 6 monthsThis is a 17-point scale with 5 choices each ranging from 17-85. Higher scores indicate worse quality of life.
Intraoperative time required for wound closureImmediately following surgeryTime for intraoperative wound closure will be monitored. Wound closure technique will be video recorded.
Percent of participants positive for superficial surgical site infection (SSI)Up to six monthsAssessed using a culture or polymerase chain reaction
Wound complications Bates-Jensen Wound Assessment Tool (BWAT) score3 and 6 monthsThe BWAT evaluates 13 categories including size, depth, edges, undermining, necrotic tissue type and amount, exudate type and amount, skin color, peripheral tissue, granulation tissue and epithelialization with a total score of 65. Minimal severity scores are 10-20 out of the total of 65 with good interrater reliability and validation in a variety of clinical environments. Wounds with scores \<10 will be considered healed. Scores will be separated into specific patient subgroups (e.g., spine procedures vs. cranial procedures, younger vs. older patients)
Liker scale of patient satisfaction with wound1, 3 and 6 months10 point subjective scale indicating patient satisfaction with wound
Wound imaging at perioperative followup1, 3 and 6 monthsWound pictures during followup period.
Wound revision strategyup to 6 monthsDescription of any wound revision strategies and timing
Number of case deviations and descriptions from prescribed suturing paradigmImmediately following surgeryA quantification and description for additional suture material required for surgical procedures will be monitored.

Countries

United States

Contacts

Primary ContactKaren Sagher
kfrisch@med.umich.edu734-232-4843

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026